|
US1082231A
(en)
*
|
1913-03-26 |
1913-12-23 |
E J Hudnall |
Method of setting tiles, bricks, and mosaics.
|
|
IT1211135B
(it)
*
|
1981-11-24 |
1989-09-29 |
Ausonia Farma Srl |
Composti ad attivita'analgesica e antiinfiammatoria, processo per la loro preparazione e relative composizioni farmaceutiche.
|
|
FR2665159B1
(fr)
*
|
1990-07-24 |
1992-11-13 |
Rhone Poulenc Sante |
Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent.
|
|
CA2400368A1
(en)
|
1992-12-02 |
1994-06-09 |
Allen J. Duplantier |
Catechol diethers as selective pde iv inhibitors
|
|
US5665777A
(en)
*
|
1995-11-14 |
1997-09-09 |
Abbott Laboratories |
Biphenyl hydroxamate inhibitors of matrix metalloproteinases
|
|
DE19633746A1
(de)
*
|
1996-08-22 |
1998-02-26 |
Basf Ag |
Substituierte 2-Phenylpyridine
|
|
US6576664B1
(en)
|
1997-08-18 |
2003-06-10 |
Bristol-Myers Squibb Pharma Company |
Inhibitors of aggrecanase and matrix metalloproteinases for the treatment of arthritis
|
|
WO1999026921A1
(en)
|
1997-11-24 |
1999-06-03 |
Merck & Co., Inc. |
SUBSTITUTED β-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS
|
|
JP2000159751A
(ja)
*
|
1998-11-20 |
2000-06-13 |
Torii Yakuhin Kk |
ベンゼン誘導体
|
|
FR2791982B1
(fr)
*
|
1999-04-06 |
2002-12-27 |
Inst Nat Sante Rech Med |
Inhibiteurs de lta4 hydrolase et leurs applications therapeutiques.
|
|
ES2247070T3
(es)
|
2000-02-16 |
2006-03-01 |
Neurogen Corporation |
Arilpirazinas sustituidas.
|
|
FR2812876B1
(fr)
|
2000-08-08 |
2002-09-27 |
Galderma Res & Dev |
Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppar-gamma et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
|
|
US6858600B2
(en)
|
2001-05-08 |
2005-02-22 |
Yale University |
Proteomimetic compounds and methods
|
|
WO2002098409A1
(en)
*
|
2001-06-07 |
2002-12-12 |
Wyeth |
Combination therapy for type ii diabetes or syndrome x
|
|
US6908939B2
(en)
|
2001-12-21 |
2005-06-21 |
Galderma Research & Development S.N.C. |
Biaromatic ligand activators of PPARγ receptors
|
|
ES2437391T3
(es)
|
2002-02-06 |
2014-01-10 |
Vertex Pharmaceuticals, Inc. |
Compuestos de heteroarilo útiles como inhibidores de GSK-3
|
|
WO2003070686A1
(en)
|
2002-02-21 |
2003-08-28 |
Asahi Kasei Pharma Corporation |
Substituted phenylalkanoic acid derivative and use thereof
|
|
PL373763A1
(en)
|
2002-04-30 |
2005-09-19 |
Ucb, S.A. |
2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors
|
|
AU2002368112A1
(en)
*
|
2002-07-29 |
2004-02-16 |
Shizuoka Coffein Co., Ltd. |
Pyrimidine derivatives
|
|
DE10250743A1
(de)
|
2002-10-31 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
|
AU2004210711B2
(en)
|
2003-02-12 |
2010-07-08 |
Transtech Pharma, Inc. |
Substituted azole derivatives as therapeutic agents
|
|
SE0301010D0
(sv)
|
2003-04-07 |
2003-04-07 |
Astrazeneca Ab |
Novel compounds
|
|
GB0312654D0
(en)
|
2003-06-03 |
2003-07-09 |
Glaxo Group Ltd |
Therapeutically useful compounds
|
|
EP1658273B1
(en)
|
2003-08-20 |
2007-01-03 |
Eli Lilly And Company |
Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
|
|
FR2869611B1
(fr)
*
|
2004-05-03 |
2006-07-28 |
Merck Sante Soc Par Actions Si |
Derives de l'acide hexenoique, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique
|
|
EP1798224A1
(en)
*
|
2004-10-05 |
2007-06-20 |
Shionogi Co., Ltd. |
Biaryl derivative
|
|
GB0422057D0
(en)
*
|
2004-10-05 |
2004-11-03 |
Astrazeneca Ab |
Novel compounds
|
|
EA013539B1
(ru)
*
|
2005-02-22 |
2010-06-30 |
Рэнбакси Лабораториз Лимитед |
Производные 5-фенилпентановой кислоты в качестве ингибиторов матричной металлопротеиназы для лечения астмы и других заболеваний
|
|
EP1883652A2
(en)
*
|
2005-05-26 |
2008-02-06 |
Bristol-Myers Squibb Company |
N-terminally modified glp-1 receptor modulators
|
|
WO2007017289A2
(en)
|
2005-08-10 |
2007-02-15 |
Bayer Schering Pharma Aktiengesellschaft |
Acyltryptophanols for fertility control
|
|
GB0525323D0
(en)
|
2005-12-13 |
2006-01-18 |
Sterix Ltd |
Compound
|
|
AU2007265373B2
(en)
|
2006-06-29 |
2013-02-21 |
Atnx Spv, Llc |
Biaryl compositions and methods for modulating a kinase cascade
|
|
ES2614931T3
(es)
|
2006-08-04 |
2017-06-02 |
Beth Israel Deaconess Medical Center |
Inhibidores de la piruvato cinasa y métodos de tratamiento de enfermedad
|
|
KR101467590B1
(ko)
*
|
2006-08-22 |
2014-12-01 |
랜박시 래보러터리스 리미티드 |
매트릭스 메탈로프로테나제 저해제
|
|
RU2009114747A
(ru)
*
|
2006-09-21 |
2010-10-27 |
Новартис АГ (CH) |
Производные пиррола, применимые в лечении цитокин-опосредованных заболеваний
|
|
JP2010505789A
(ja)
*
|
2006-10-04 |
2010-02-25 |
エフ．ホフマン−ラ ロシュ アーゲー |
Ｈｄｌ−コレステロール上昇剤としての３−ピリジンカルボキサミド及び２−ピラジンカルボキサミド誘導体
|
|
US8153660B2
(en)
*
|
2006-10-27 |
2012-04-10 |
Boehringer Ingelheim International Gmbh |
Piperidyl-propane-thiol CCR3 modulators
|
|
WO2008066131A1
(en)
*
|
2006-12-01 |
2008-06-05 |
Banyu Pharmaceutical Co., Ltd. |
Novel phenyl-isoxazol-3-ol derivative
|
|
US20110009384A1
(en)
|
2007-02-09 |
2011-01-13 |
Takeda Pharmaceutical Company Limited |
Fused ring compounds as partial agonists of ppar-gamma
|
|
KR20090113901A
(ko)
*
|
2007-02-22 |
2009-11-02 |
아이알엠 엘엘씨 |
Ｇ 단백질-커플링된 수용체를 조절하기 위한 화합물 및 방법
|
|
CA2677705A1
(en)
*
|
2007-02-22 |
2008-08-28 |
Irm Llc |
Thiazole derivatives as modulators of g protein-coupled receptors
|
|
WO2008139987A1
(ja)
*
|
2007-04-26 |
2008-11-20 |
Japan Science And Technology Agency |
Ｇタンパク質共役型レセプタ－作動剤
|
|
DK2152670T3
(en)
*
|
2007-04-27 |
2014-02-24 |
Actelion Pharmaceuticals Ltd |
BROKEN SEX-LEADED RING CONNECTIONS
|
|
WO2009011285A1
(ja)
*
|
2007-07-13 |
2009-01-22 |
Taisho Pharmaceutical Co., Ltd. |
ヘテロアリールベンゼン化合物
|
|
JP4834699B2
(ja)
*
|
2007-07-30 |
2011-12-14 |
田辺三菱製薬株式会社 |
医薬組成物
|
|
WO2009074829A1
(en)
|
2007-12-12 |
2009-06-18 |
Astrazeneca Ab |
Peptidyl nitriles and use thereof as dipeptidyl peptidase i inhibitors
|
|
US20110039860A1
(en)
*
|
2008-05-07 |
2011-02-17 |
Cangming Yang |
Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment
|
|
MX2010014569A
(es)
|
2008-06-24 |
2011-03-29 |
Irm Llc |
Compuestos y metodos para modular los receptores acoplados con proteina-g.
|
|
JP2012506386A
(ja)
*
|
2008-10-21 |
2012-03-15 |
メタボレックス， インコーポレイテッド |
アリールｇｐｒ１２０受容体アゴニストおよびその使用
|
|
EP2352374B1
(en)
|
2008-10-29 |
2014-09-24 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
TW201031649A
(en)
|
2008-12-02 |
2010-09-01 |
Organon Nv |
1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives
|
|
WO2010070076A1
(en)
*
|
2008-12-19 |
2010-06-24 |
Crystax Pharmaceuticals, S.L. |
Alkanoic acid derivatives and their therapeutic use as hdac inhibitors
|
|
EP2423176A4
(en)
|
2009-04-22 |
2012-11-07 |
Astellas Pharma Inc |
CARBOXYLIC ACID COMPOUND
|
|
CA2763565A1
(en)
|
2009-05-28 |
2010-12-02 |
Novartis Ag |
Substituted aminobutyric derivatives as neprilysin inhibitors
|
|
US8586776B2
(en)
*
|
2009-11-05 |
2013-11-19 |
Fibrostatin, S.L. |
GPBP inhibition using Q2 peptidomimetics
|
|
AR081930A1
(es)
*
|
2010-06-16 |
2012-10-31 |
Ardea Biosciences Inc |
Compuestos de tioacetato
|
|
JP5746334B2
(ja)
*
|
2010-06-16 |
2015-07-08 |
シマベイ セラピューティクス， インコーポレーテッド |
Ｇｐｒ１２０受容体作動薬及びその使用
|
|
JP2013540145A
(ja)
|
2010-10-21 |
2013-10-31 |
ウニベルシテート デス ザールランデス |
コルチゾール依存性疾患の治療用の選択的ｃｙｐ１１ｂ１阻害剤
|
|
US8673974B2
(en)
|
2010-11-16 |
2014-03-18 |
Novartis Ag |
Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
|
|
NZ610983A
(en)
|
2010-12-15 |
2014-10-31 |
Theravance Biopharma R & D Ip Llc |
Neprilysin inhibitors
|
|
EP2651930B1
(en)
*
|
2010-12-16 |
2015-10-28 |
Boehringer Ingelheim International GmbH |
Biarylamide inhibitors of leukotriene production
|
|
WO2012081736A1
(en)
*
|
2010-12-17 |
2012-06-21 |
Mitsubishi Tanabe Pharma Corporation |
Continuous arycyclic compound
|
|
JP5842630B2
(ja)
*
|
2011-03-16 |
2016-01-13 |
株式会社リコー |
カルバゾール誘導体、及び半導体ナノ結晶
|
|
US20140303163A1
(en)
|
2011-03-24 |
2014-10-09 |
Ying Luo |
Use of kinase inhibitors in preventing and treating inflammatory disorder
|
|
US9145391B2
(en)
*
|
2011-05-10 |
2015-09-29 |
Merck Sharp & Dohme Corp. |
Bipyridylaminopyridines as Syk inhibitors
|
|
WO2013056679A1
(en)
*
|
2011-10-21 |
2013-04-25 |
Beijing Hanmi Pharmaceutical Co., Ltd |
Novel heteroaryl-amino derivatives
|
|
WO2013139341A1
(en)
*
|
2012-03-20 |
2013-09-26 |
Syddansk Universitet |
Gpr120 receptor modulators
|
|
HK1206735A1
(en)
*
|
2012-04-06 |
2016-01-15 |
辉瑞公司 |
Diacylglycerol acyltransferase 2 inhibitors
|
|
PT2859009T
(pt)
*
|
2012-06-08 |
2018-01-18 |
Gilead Sciences Inc |
Inibidores macrocíclicos dos vírus flaviviridae
|
|
WO2013185766A1
(en)
|
2012-06-15 |
2013-12-19 |
Syddansk Universitet |
Gpr120 receptor modulators
|
|
AU2013329064A1
(en)
|
2012-10-11 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Substituted spiropiperidinyl compounds useful as GPR120 agonists
|
|
ES2749467T3
(es)
*
|
2012-11-20 |
2020-03-20 |
Biogen Ma Inc |
Agentes moduladores de S1p y/o ATX
|
|
JP6401773B2
(ja)
|
2013-03-11 |
2018-10-10 |
ザ リージェンツ オブ ザ ユニヴァシティ オブ ミシガン |
Ｂｅｔブロモドメイン阻害剤およびこれを用いる治療方法
|
|
SG11201506796XA
(en)
*
|
2013-03-14 |
2015-09-29 |
Bristol Myers Squibb Co |
Bicyclo [2.2.1] acid gpr120 modulators
|
|
JP6322704B2
(ja)
*
|
2013-06-27 |
2018-05-09 |
エルジー・ケム・リミテッド |
Ｇｐｒ１２０アゴニストとしてのビアリール誘導体
|
|
WO2016040222A1
(en)
*
|
2014-09-09 |
2016-03-17 |
Bristol-Myers Squibb Company |
Cyclopropanecarboxylic acid gpr120 modulators
|
|
WO2016038540A1
(en)
*
|
2014-09-11 |
2016-03-17 |
Piramal Enterprises Limited |
Fused heterocyclic compounds as gpr120 agonists
|
|
AU2015324914B2
(en)
|
2014-10-02 |
2018-10-04 |
Neurobiogen Co., Ltd. |
Alpha-aminoamide derivative compound and pharmaceutical composition containing the same
|